NWPF

News Archives

Filtered by: July 2005

Melbourne scientists in Parkinson’s breakthrough

Thursday July 28, 2005

A team of scientists from Melbourne University and the Mental Health Research Institute said their discovery of interactions between certain molecules characteristic of Parkinson’s disease could lead to a greater understanding of how the disease works and can be treated.

Read Aricle

Free DVD About Parkinson’s Disease

Thursday July 28, 2005


Read Aricle

Avigen Announces Encouraging Early Data From Parkinson’s Disease Clinical Trial

Thursday July 28, 2005


Avigen, Inc. today announced encouraging results from the first patient treated in a Phase I/II clinical trial of AV201, the Company’s drug candidate for the treatment of mid- to later-stage Parkinson’s disease. The results from positron emission tomography (PET) brain scans obtained six months after AV201 infusion indicated an increased activity of the gene product, aromatic L-amino acid decarboxylase (AADC) in the targeted area of the brain, compared with the patient’s pre-treatment PET scans. These findings are consistent with increased dopamine production and transgene expression.

Read Aricle

Compulsive Gambling, Sex Linked to Parkinson’s Drugs

Thursday July 28, 2005

Scientists at the Mayo Clinic in Rochester, Minnesota, have found that certain drugs used to treat Parkinson’s disease can cause patients to become addicted to gambling. The drugs, called dopamine agonists, also have been found to boost patients’ appetites for sex, food, and alcohol.

Read Aricle

Adult stem cell breakthrough in search for Parkinson’s therapy

Thursday July 28, 2005

Researchers collaborating with Brainstorm Cell Therapeutics have successfully used adult stem cells to produce GDNF, a substance that holds great promise in the treatment of Parkinson’s and other neurodegenerative diseases.

Read Aricle

Therapy activates brain stem cells

Thursday July 28, 2005

The paper describes how the scientists used gene-nanoparticle complexes to activate adult brain stem/progenitor cells in vivo, demonstrating that it may be possible to "turn on" these otherwise idle cells as effective replacements for those destroyed by neurodegenerative diseases, such as Parkinson’s.

Read Aricle

Just 1% of Parkinson’s Patients Involved in Clinical Trials

Friday July 22, 2005

The Michael J Fox Foundation, and a consortium of Parkinson’s disease advocacy groups - "The Advancing Parkinson’s Therapy (APT) coalition," has announced the results of a major Harris poll that reveals the following information:

- Only one percent of people with Parkinson’s are currently participating in clinical research.

Read Aricle

Parkinson’s patients find support in each other

Friday July 22, 2005

It takes a team of family, friends, therapists and doctors, along with a big dose of self-determination, to keep them going.

Mary McDaniel, Ron Coleman and Bob Murr suffer from Parkinson’s disease. Although their initial symptoms were different, their struggles are much the same.

Read Aricle

New way of getting help for Parkinson’s patients

Friday July 22, 2005


Read Aricle

Case inspires Parkinson’s crusade

Friday July 22, 2005

Parkinson’s patients in the US, who are suing a drugs company for withdrawing a pioneering treatment, say a man treated in Bristol has given them fresh hope. Amgen halted medical trials of glial cell line-derived neurotrophic factor (GDNF) because of side effects.

Read Aricle
<< Back 1 - 10 of 23 Next >>